ABOUT RIGHT OF ASSEMBLY

Right of Assembly is my personal blog. All opinions are my own. You can read more about me here.

DISCLOSURE

I am a ChromaDex shareholder, and an affiliate marketer. As a result, I will sometimes mention or recommend products that I endorse. I may earn a small commission from qualifying purchases if you were referred directly from this site and completed a purchase. [Thank you!] You can read more about our advertising, privacy, and data collection policies here. 

Cookies

This site uses cookies. Cookies are not required for site functionality. You can read more about how to opt-out of cookies here.

  • Shelly Albaum

CDXC Answers Third Amended Counterclaims


Today ChromaDex filed its answer to Elysium's Third Amended Counterclaims. You can read the answer here:

ChromaDex's Answer to Elysium's TACC

The answer is mostly just a denial of all material allegations, and there is little new or unexpected as compared to ChromaDex's previous answer to Elysium's Second Amended Counterclaims, with the possible exception of this particular denial:

ChromaDex admits that it provided to some customers, not including Elysium, statements signed by the company’s Director of Quality Assurance attesting to the fact that its nicotinamide riboside was tested for chemicals subject to the requirements of California’s voter initiative. (emphasis added)

This new pleading has been added to our Litigation Documents page.

#CDXC #ChromaDex #ElysiumHealth #Litigation

105 views